IN2014DN07767A - - Google Patents

Info

Publication number
IN2014DN07767A
IN2014DN07767A IN7767DEN2014A IN2014DN07767A IN 2014DN07767 A IN2014DN07767 A IN 2014DN07767A IN 7767DEN2014 A IN7767DEN2014 A IN 7767DEN2014A IN 2014DN07767 A IN2014DN07767 A IN 2014DN07767A
Authority
IN
India
Prior art keywords
amino
salt
polyoxyethylene sorbitan
sorbitan fatty
fatty acid
Prior art date
Application number
Other languages
English (en)
Inventor
Takashi Morimoto
Hiroyuki Asada
Kyohei Takahashi
Tomoyuki Okamoto
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of IN2014DN07767A publication Critical patent/IN2014DN07767A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IN7767DEN2014 2012-03-28 2013-03-28 IN2014DN07767A (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012073181 2012-03-28
PCT/JP2013/059211 WO2013147000A1 (ja) 2012-03-28 2013-03-28 2-アミノ-3-(4-ブロモベンゾイル)フェニル酢酸含有水性組成物

Publications (1)

Publication Number Publication Date
IN2014DN07767A true IN2014DN07767A (cg-RX-API-DMAC7.html) 2015-05-15

Family

ID=49260248

Family Applications (1)

Application Number Title Priority Date Filing Date
IN7767DEN2014 IN2014DN07767A (cg-RX-API-DMAC7.html) 2012-03-28 2013-03-28

Country Status (9)

Country Link
JP (1) JP5922609B2 (cg-RX-API-DMAC7.html)
KR (1) KR20140139501A (cg-RX-API-DMAC7.html)
CN (1) CN104203224A (cg-RX-API-DMAC7.html)
IN (1) IN2014DN07767A (cg-RX-API-DMAC7.html)
MY (1) MY170840A (cg-RX-API-DMAC7.html)
PH (1) PH12014502171A1 (cg-RX-API-DMAC7.html)
SG (1) SG11201405837YA (cg-RX-API-DMAC7.html)
TW (1) TWI604858B (cg-RX-API-DMAC7.html)
WO (1) WO2013147000A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180016469A (ko) * 2015-06-10 2018-02-14 산텐 세이야꾸 가부시키가이샤 점안제, 및 점안제 방부 효력 유지 방법
JPWO2019117252A1 (ja) * 2017-12-14 2020-12-17 参天製薬株式会社 2−アミノ−3−(4−ブロモベンゾイル)フェニル酢酸またはその塩を含有する点眼剤
CN114224830A (zh) * 2021-12-24 2022-03-25 辰欣药业股份有限公司 一种单剂量无抑菌剂的眼用制剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002308764A (ja) * 2001-02-09 2002-10-23 Taisho Pharmaceut Co Ltd 眼科用医薬組成物
JP4674162B2 (ja) * 2003-11-14 2011-04-20 千寿製薬株式会社 アミノグリコシド系抗生物質およびブロムフェナクを含有する水溶液製剤
CN1823754A (zh) * 2006-03-28 2006-08-30 卢秀莲 溴芬酸钠滴眼液及其制备方法
CN101313899B (zh) * 2007-06-01 2012-02-29 北京德众万全药物技术开发有限公司 一种含有溴芬酸钠的眼用药物组合物
CA2716110A1 (en) * 2008-02-21 2009-08-27 Tim Mcnamara Ophthalmic nsaids as adjuvants
CN101322683B (zh) * 2008-07-30 2013-01-16 浙江三叶药业有限公司 一种含有溴芬酸钠水合物的眼用凝胶剂及其制备方法
US9107888B2 (en) * 2011-01-18 2015-08-18 Senju Pharmaceutical Co., Ltd. Aqueous liquid bromfenac composition having preservative efficacy
JP6012231B2 (ja) * 2011-04-08 2016-10-25 ロート製薬株式会社 ブロムフェナク含有組成物

Also Published As

Publication number Publication date
WO2013147000A1 (ja) 2013-10-03
CN104203224A (zh) 2014-12-10
TWI604858B (zh) 2017-11-11
SG11201405837YA (en) 2014-11-27
KR20140139501A (ko) 2014-12-05
PH12014502171A1 (en) 2014-12-10
JP5922609B2 (ja) 2016-05-24
TW201343197A (zh) 2013-11-01
JP2013227300A (ja) 2013-11-07
MY170840A (en) 2019-09-10

Similar Documents

Publication Publication Date Title
EA201390074A1 (ru) 5-хлор-4-гидрокси-1-метил-2-оксо-n-фенил-1,2-дигидрохинолин-3-карбоксамид, его соли и применения
PH12015502031B1 (en) Tetrahydropyrrolothiazine compounds
UY34763A (es) Inhibidores de la agregación plaquetaria
HK1210696A1 (en) Irak inhibitors and uses thereof
MX2016003843A (es) Inhibidores de cinasas asociadas al receptor de interleucina 1 (irak) y usos de los mismos.
MX2015002040A (es) Baricitinib deuterado.
EP3046932A4 (en) Evolved sortases and uses thereof
MA39095A1 (fr) Anticorps et immunoconjugués anti-cd33
HK1216859A1 (zh) Irak抑制劑和其用途
MX2015015421A (es) Inhibidores de acetil-coa carboxilasa (acc) y usos de los mismos.
PH12013500246A1 (en) Besylate salt of a btk inhibitor
MX351513B (es) Compuesto de alquinilbenceno 3,5-disustituido y sales del mismo.
MX2015015417A (es) Inhibidores de acetil-coa carboxilasa (acc) y usos de los mismos.
IN2015DN00598A (cg-RX-API-DMAC7.html)
EA201690911A1 (ru) Соединения диметилбензойной кислоты
MX2015011837A (es) Co-cristale de pirimetanil y tetracarboximida de ditiina seleccionada.
CA2875305C (en) Fbxo3 inhibitors
IL241245A0 (en) Bicyclo [2.2.1] acid gpr120 modulators
HK1222848A1 (zh) 用作alk抑制剂的吡咯并三嗪
AU2014224814A8 (en) Novel halogen-substituted compounds
UA115072C2 (uk) Похідні гідантоїну
PH12014501840A1 (en) Pharmaceutical formulation having improved stability
CL2015002350A1 (es) Composición agroquimica en suspensión acuosa
PH12014502171A1 (en) Aqueous composition containing 2-amino-3-(4-bromobenzoyl)- phenylacetic acid
WO2013188789A3 (en) Genome-wide method of assessing interactions between chemical entities and their target molecules